Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung.

Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung. J Clin Invest. 1985 May; 75(5):1690-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.